BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20385569)

  • 1. Relation between kidney function, proteinuria, and adverse outcomes--a critical look at the application of medical statistics in the Nephrology literature.
    Onuigbo MA
    QJM; 2010 Jul; 103(7):537-8. PubMed ID: 20385569
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of proteinuria: CKD progression and cardiovascular outcomes.
    Sarnak MJ; Astor BC
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):258-66. PubMed ID: 21782132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.
    Tonelli M; Jose P; Curhan G; Sacks F; Braunwald E; Pfeffer M;
    BMJ; 2006 Jun; 332(7555):1426. PubMed ID: 16714328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
    Ovbiagele B; Sanossian N; Liebeskind DS; Kim D; Ali LK; Pineda S; Saver JL
    Cerebrovasc Dis; 2009; 28(6):582-8. PubMed ID: 19844098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study".
    Barrios V; Escobar C; Echarri R
    Circulation; 2009 Nov; 120(18):e153; author reply e154. PubMed ID: 19884478
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
    J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.
    Johnson CA; Levey AS; Coresh J; Levin A; Lau J; Eknoyan G
    Am Fam Physician; 2004 Sep; 70(6):1091-7. PubMed ID: 15456118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic kidney disease and global cardiovascular risk in essential hypertension.
    Segura J; Campo C; Ruilope LM
    Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors in progressive renal injury. The role of proteinuria.
    D'Amico G
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):48-52. PubMed ID: 2024673
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for the evaluation of the severity of established renal disease. Council on the Kidney in Cardiovascular disease. American Heart Association, 1971.
    Ann Intern Med; 1971 Aug; 75(2):251-2. PubMed ID: 5558653
    [No Abstract]   [Full Text] [Related]  

  • 18. CKD prognosis: beyond the traditional outcomes.
    Coresh J
    Am J Kidney Dis; 2009 Jul; 54(1):1-3. PubMed ID: 19559334
    [No Abstract]   [Full Text] [Related]  

  • 19. The primary care physician: nephrology interface for the identification and treatment of chronic kidney disease.
    Stevens PE; Farmer CK; Hallan SI
    J Nephrol; 2010; 23(1):23-32. PubMed ID: 20091483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteinuria. Characteristics of normal glomerular permeability in various nephropathies].
    de Faria CV
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(4):352-61. PubMed ID: 968329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.